Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV-Reference-Cited by-同舟云学术

Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV

Published:2015-03-06 Issue:6 Volume:10 Page:1456-1465
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Lee Hyun¹,Lei Hao¹,Santarsiero Bernard D.¹,Gatuz Joseph L.¹,Cao Shuyi¹,Rice Amy J.¹,Patel Kavankumar¹,Szypulinski Michael Z.¹,Ojeda Isabel,Ghosh Arun K.²,Johnson Michael E.¹

Affiliation:

1. Center for Pharmaceutical Biotechnology and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 900 S. Ashland, Chicago, Illinois 60607, United States

2. Departments of Chemistry and Medicinal Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/cb500917m

Reference44 articles.

1. Emerging Human Coronaviruses — Disease Potential and Preparedness

2. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

3. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

4. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group

5. World Health Organization (2014). Middle East respiratory syndrome coronavirus (MERS-CoV) – update. http://www.who.int/csr/don/2014_07_23_mers/en/.

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure–activity relationships;Bioorganic & Medicinal Chemistry;2024-09

2. Discovery of SARS-CoV-2 papain-like protease (PL ^pro ) inhibitors with efficacy in a murine infection model;Science Advances;2024-08-30

3. Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (M^pro);ACS Omega;2024-08-02

4. Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape;Nature Communications;2024-07-23

5. Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir;npj Viruses;2024-06-24